OUTLINE GUIDE TO MANAGEMENT OF DIABETIC KETOACIDOSIS IN
ADULTS
By Dr. V. Lavis
Last revision 12/19/03 1:47 PM
Reference:
Diabetes Care 2002; 25(Suppl. 1):S100‑S108
·
Rapid examination for airway, cardiovascular
function, neurologic status, signs of infection
·
Capillary blood glucose and urinary ketones
·
Stat blood work: arterial gases, serum Na, K, Cl,
HCO3-, glucose, creatinine, BUN; CBC. Calculate serum osmolality and anion gap
·
Stat ECG
·
Start a flow sheet
·
Chest film if indicated
·
Cultures: blood, urine, sputum
Initial therapy
·
NG tube if patient is unconscious or vomiting.
·
Hemodynamic monitoring if there is suspicion of
·
DVT prophylaxis, especially if patient is
unconscious or severely volume-depleted.
·
0.9% saline: 1 L in 30 min; then
1 L in next 1 hour; then 1 L in next 2 hours; then 2 L
in next 8 hours
·
Switch to 0.45% saline if osmolality increases
during administration of saline, or if
[serum Na + 0.016 • (serum glucose – 100)] > 145.
·
Check serum K.
Hold insulin if K<3.3 mEq/L.
Give KCl at 40 mEq/h, until K≥3.3 mEq/L.
·
Load with 0.15 units/kg Regular, IV; then start
infusion at 0.1 units/kg/h.
·
Double rate of infusion if glucose does not fall by
at least 50 mg/dl in 1 h.
Double rate hourly, until glucose falls by at least 50 mg/dl/h.
·
Be sure patient is making urine.
·
If K<3.3 mEq/L, hold insulin. Give 40 mEq K/h, until
K≥3.3 mEq/L.
·
If K between 3.3 and 4 mEq/L, give
25 mEq K/h.
·
If K between 4 and 5 mEq/L, give
20 mEq K/h.
·
If K rises above 5 mEq/L, stop giving K; check
K level q2h.
·
K infusion should be 2/3 as KCl, 1/3 as
K phosphate.
·
Adjust rate of K infusion to keep serum K
between 4 and 5 mEq/L.
·
Monitor ECG as guide to extracellular [K+]
·
If arterial pH>7.0, no need for bicarbonate
·
For pH 6.9 ‑ 7.0, may give
44 mEq NaHCO3, with 10 ‑ 15 mEq K+, over
30 min
·
For pH <6.9, give 88 mEq NaHCO3, with
25 mEq K+, over 45 min
·
30 min after each infusion of NaHCO3,
re-check pH, and re-evaluate need for more alkali
·
Patients in DKA are usually phosphate depleted, but
not hypophosphatemic on admission; serum phosphate usually falls during therapy
·
Controlled studies have failed to show a beneficial
effect of intravenous phosphate replacement on clinical outcome, in diabetic
ketoacidosis.
·
Do not give IV phosphate if patient is
hyperphosphatemic, hypercalcemic, hypocalcemic, azotemic or oliguric
·
Check P level initially and 8 hr. after
starting insulin
·
If [P] <1 mg/dL, may give neutral
K phosphate, 10 ‑ 20 millimoles per liter of IV
fluids
·
Do not add phosphate to solutions containing calcium
·
Monitor serum Ca, P and creatinine q12 h, while
giving IV phosphate
·
Safest way to replete phosphate is orally, after
patient can take oral feedings
Continued management
·
When glucose down to 250 mg/dL:
o
Switch to fluids containing 5% or 10% dextrose,
until patient can eat
o
Patient will develop a non-anion-gap acidosis, during
the treatment. Continue insulin infusion
at therapeutic rate of at least 5 units/hr, until the acidosis has cleared
(i.e. [HCO3‑] >18 mEq/L). Give dextrose-containing fluids as needed to
avoid hypoglycemia
o
After acidosis has cleared, continue insulin infusion
at maintenance rate of 0.5 ‑ 2 units/hr, until patient can
eat
o
Keep giving IV K+ at about 3 ‑ 5 mEq/hr,
until patient begins eating
·
Wait at least 1 hr after giving
NPH insulin, before stopping the insulin infusion.
·
Remember that a Type 1 diabetic patient will
require NPH insulin twice daily
·
Continue oral K+ and phosphate repletion
for 5 to 7 days